PATENT CLAIM ANALYSIS

Application Number: 15920924
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["514", "002400"]

Abstract:
The present invention provides proteins that are suitable to be used as the active ingredient in subunit vaccine against  Mycoplasma  spp. The present invention also provides a subunit vaccine made therefrom. Said proteins have been experimentally proved to have the capability of inducing sufficient immune response to avoid pigs from  Mycoplasma  spp. infection. Said vaccine may have one of said proteins as active ingredient; or may have two or more of said proteins and is formulated as a cocktail vaccine. The present vaccine not only is safer than the conventional vaccines but also has equal or even better immune efficiency than the conventional ones. Furthermore, fusion partners suitable for producing said proteins of high solubility are also proved, which can significantly reduce production cost.

Claim (Index 1):
A composition, comprising:\n an active ingredient, comprising P46; wherein said P46 comprises SEQ ID NO: 01; and an immune-effective amount of a pharmaceutically acceptable adjuvant.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 90.0
- Lexical Diversity: 1.6962
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15032758', '15453684', '14765512', '15453660', '15453760']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8153710135187033
- 35 USC 102 Novelty (BERT): 0.5438926939045737
- Combined Prediction Score: 0.7882231815572904
- Mean Citation Score: 377.748556
- Max Citation Score: 426.62222
- Similarity Product: 256.4739054592431

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test